Hyperactive behaviour in the mouse model of mucopolysaccharidosis iiib in the open field and home cage environments

Genes, Brain and Behavior

Volumn 10, Issue 6, 2011, Pages 673-682

  Langford Smith, A ^a   Malinowska, M ^a,b   Langford Smith, K J ^a   Wegrzyn, G ^b   Jones, S ^c   Wynn, R ^d   Wraith, J E ^c   Wilkinson, F L ^a   Bigger, B W ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF GDA SK   (Poland)

^c ST MARY S HOSPITAL   (United Kingdom)

^d ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Behaviour; Lysosomal storage disease; MPS IIIB; Mucopolysaccharidosis; Neurodegenerative disease; Open field; Sanfilippo syndrome

Indexed keywords

ACCLIMATIZATION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREEDING; CAGE; CONTROLLED STUDY; EXPLORATORY BEHAVIOR; FEMALE; HABITUATION; HOME CAGE BEHAVIOR; HYPERACTIVITY; HYPOTHESIS; IMMOBILIZATION; LIGHT; MOUSE; MUCOPOLYSACCHARIDOSIS; NEUROPATHOLOGY; NONHUMAN; OPEN FIELD BEHAVIOR; OPEN FIELD TEST; PHENOTYPE; PRIORITY JOURNAL; SANFILIPPO SYNDROME TYPE B; WILD TYPE;

ACETYLGLUCOSAMINIDASE; ANIMALS; ANXIETY; DISEASE MODELS, ANIMAL; ENVIRONMENT; EXPLORATORY BEHAVIOR; HYPERKINESIS; MICE; MICE, KNOCKOUT; MOTOR ACTIVITY; MUCOPOLYSACCHARIDOSIS III;

MUS;

EID: 79961023079     PISSN: 16011848     EISSN: 1601183X     Source Type: Journal    
DOI: 10.1111/j.1601-183X.2011.00706.x     Document Type: Article

References (27)

1. Canal, M.M., Wilkinson, F.L., Cooper, J.D., Wraith, J.E., Wynn, R. & Bigger, B.W. (2010) Circadian rhythm and suprachiasmatic nucleus alterations in the mouse model of mucopolysaccharidosis IIIB. Behav Brain Res 209, 212-220.
2. Cleary, M.A. & Wraith, J.E. (1993) Management of mucopolysaccharidosis type III. Arch Dis Child 69, 403-406.
3. Constantopoulos, G., Eiben, R.M. & Schafer, I.A. (1978) Neurochemistry of the mucopolysaccharidoses: brain glycosaminoglycans, lipids and lysosomal enzymes in mucopolysaccharidosis type III B (alpha-N-acetylglucosaminidase deficiency). J Neurochem 31, 1215-1222.
4. Crawley, J.N. (2007) What's Wrong with My Mouse?: Behavioral Phenotyping of Transgenic and Knockout Mice. John Wiley, Hoboken, NJ.
5. Cressant, A., Desmaris, N., Verot, L., Brejot, T., Froissart, R., Vanier, M.T., Maire, I. & Heard, J.M. (2004) Improved behavior and neuropathology in the mouse model of Sanfilippo type IIIB disease after adeno-associated virus-mediated gene transfer in the striatum. J Neurosci 24, 10229-10239.
6. Fraser, J., Wraith, J.E. & Delatycki, M.B. (2002) Sleep disturbance in mucopolysaccharidosis type III (Sanfilippo syndrome): a survey of managing clinicians. Clin Genet 62, 418-421.
7. Fraser, J., Gason, A.A., Wraith, J.E. & Delatycki, M.B. (2005) Sleep disturbance in Sanfilippo syndrome: a parental questionnaire study. Arch Dis Child 90, 1239-1242.
8. Fu, H., Kang, L., Jennings, J.S., Moy, S.S., Perez, A., Dirosario, J., McCarty, D.M. & Muenzer, J. (2007) Significantly increased lifespan and improved behavioral performances by rAAV gene delivery in adult mucopolysaccharidosis IIIB mice. Gene Ther 14, 1065-1077.
9. Fu, H., DiRosario, J., Kang, L., Muenzer, J. & McCarty, D.M. (2010) Restoration of central nervous system alpha-N-acetylglucosaminidase activity and therapeutic benefits in mucopolysaccharidosis IIIB mice by a single intracisternal recombinant adeno-associated viral type 2 vector delivery. J Gene Med 12, 624-633.
10. Heldermon, C.D., Hennig, A.K., Ohlemiller, K.K., Ogilvie, J.M., Herzog, E.D., Breidenbach, A., Vogler, C., Wozniak, D.F. & Sands, M.S. (2007) Development of sensory, motor and behavioral deficits in the murine model of Sanfilippo syndrome type B. PLoS One 2, e772.
11. Heldermon, C.D., Ohlemiller, K.K., Herzog, E.D., Vogler, C., Qin, E., Wozniak, D.F., Tan, Y., Orrock, J.L. & Sands, M.S. (2010) Therapeutic efficacy of bone marrow transplant, intracranial AAV-mediated gene therapy, or both in the mouse model of MPS IIIB. Mol Ther 18, 873-880.
12. Hemsley, K.M. & Hopwood, J.J. (2005) Development of motor deficits in a murine model of mucopolysaccharidosis type IIIA (MPS-IIIA). Behav Brain Res 158, 191-199.
13. Heron, B., Mikaeloff, Y., Froissart, R., Caridade, G., Maire, I., Caillaud, C., Levade, T., Chabrol, B., Feillet, F., Ogier, H., Valayannopoulos, V., Michelakakis, H., Zafeiriou, D., Lavery, L., Wraith, E., Danos, O., Heard, J.M. & Tardieu, M. (2011) Incidence and natural history of mucopolysaccharidosis type III in France and comparison with United Kingdom and Greece. Am J Med Genet A 155A, 58-68.
14. Langford-Smith, K., Arasaradnam, M., Wraith, J.E., Wynn, R. & Bigger, B.W. (2010) Evaluation of heparin cofactor II-thrombin complex as a biomarker on blood spots from mucopolysaccharidosis I, IIIA and IIIB mice. Mol Genet Metab 99, 269-274.
15. Langford-Smith, K.J., Mercer, J., Petty, J., Tylee, K., Church, H., Roberts, J., Moss, G., Jones, S., Wynn, R., Wraith, J.E. & Bigger, B.W. (2011) Heparin cofactor II-thrombin complex and dermatan sulphate:chondroitin sulphate ratio are biomarkers of short- and long-term treatment effects in mucopolysaccharide diseases. J Inherit Metab Dis 34, 499-508.
16. Li, H.H., Yu, W.H., Rozengurt, N., Zhao, H.Z., Lyons, K.M., Anagnostaras, S., Fanselow, M.S., Suzuki, K., Vanier, M.T. & Neufeld, E.F. (1999) Mouse model of Sanfilippo syndrome type B produced by targeted disruption of the gene encoding alpha-N-acetylglucosaminidase. Proc Natl Acad Sci U S A 96, 14505-14510.
17. Malinowska, M., Wilkinson, F.L., Bennett, W., Langford-Smith, K.J., O'Leary, H.A., Jakobkiewicz-Banecka, J., Wynn, R., Wraith, J.E., Wegrzyn, G. & Bigger, B.W. (2009) Genistein reduces lysosomal storage in peripheral tissues of mucopolysaccharide IIIB mice. Mol Genet Metab 98, 235-242.
18. Malinowska, M., Wilkinson, F.L., Langford-Smith, K.J., Langford-Smith, A., Brown, J.R., Crawford, B.E., Vanier, M.T., Grynkiewicz, G., Wynn, R.F., Wraith, J.E., Wegrzyn, G. & Bigger, B.W. (2010) Genistein improves neuropathology and corrects behaviour in a mouse model of neurodegenerative metabolic disease. PLoS One 5, e14192.
19. McGlynn, R., Dobrenis, K. & Walkley, S.U. (2004) Differential subcellular localization of cholesterol, gangliosides, and glycosaminoglycans in murine models of mucopolysaccharide storage disorders. J Comp Neurol 480, 415-426.
20. Meyer, A., Kossow, K., Gal, A., Muhlhausen, C., Ullrich, K., Braulke, T. & Muschol, N. (2007) Scoring evaluation of the natural course of mucopolysaccharidosis type IIIA (Sanfilippo syndrome type A). Pediatrics 120, e1255-1261.
21. Moog, U., van Mierlo, I., van Schrojenstein Lantman-de Valk, H.M., Spaapen, L., Maaskant, M.A. & Curfs, L.M. (2007) Is Sanfilippo type B in your mind when you see adults with mental retardation and behavioral problems? Am J Med Genet C Semin Med Genet 145C, 293-301.
22. O'Brien, J.S. (1972) Sanfilippo syndrome: profound deficiency of alpha-acetylglucosaminidase activity in organs and skin fibroblasts from type-B patients. Proc Natl Acad Sci U S A 69, 1720-1722.
23. Ohmi, K., Greenberg, D.S., Rajavel, K.S., Ryazantsev, S., Li, H.H. & Neufeld, E.F. (2003) Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB. Proc Natl Acad Sci U S A 100, 1902-1907.
24. Simon, P., Dupuis, R. & Costentin, J. (1994) Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions. Behav Brain Res 61, 59-64.
25. Valstar, M.J., Ruijter, G.J., van Diggelen, O.P., Poorthuis, B.J. & Wijburg, F.A. (2008) Sanfilippo syndrome: a mini-review. J Inherit Metab Dis 31, 240-252.
26. Yu, W.H., Zhao, K.W., Ryazantsev, S., Rozengurt, N. & Neufeld, E.F. (2000) Short-term enzyme replacement in the murine model of Sanfilippo syndrome type B. Mol Genet Metab 71, 573-580.
27. Zhao, H.G., Li, H.H., Bach, G., Schmidtchen, A. & Neufeld, E.F. (1996) The molecular basis of Sanfilippo syndrome type B. Proc Natl Acad Sci U S A 93, 6101-6105.